menu
    • menu
    [{"orgOrder":0,"company":"Vensica Therapeutics","sponsor":"Merz Pharma","pharmaFlowCategory":"D","therapeuticArea":"Urology","country":"ISRAEL","productType":"Protein","year":"2022","type":"Partnership","leadProduct":"Incobotulinumtoxin A","moa":"SNAP25","graph1":"Urology","graph2":"Phase III","graph3":"Vensica Therapeutics","amount2":0.02,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Urology","amount2New":0.02,"dosageForm":"Injection","sponsorNew":"Vensica Therapeutics \/ Merz Pharma","highestDevelopmentStatusID":"10","companyTruncated":"Vensica Therapeutics \/ Merz Pharma"},{"orgOrder":0,"company":"Vensica Therapeutics","sponsor":"Blueclinical","pharmaFlowCategory":"DU","therapeuticArea":"Urology","country":"ISRAEL","productType":"Protein","year":"2024","type":"Inapplicable","leadProduct":"Xeomin","moa":"SNAP25","graph1":"Urology","graph2":"Undisclosed","graph3":"Vensica Therapeutics","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Urology","amount2New":0,"dosageForm":"Liquid, Instillation","sponsorNew":"Vensica Therapeutics \/ Blueclinical","highestDevelopmentStatusID":"1","companyTruncated":"Vensica Therapeutics \/ Blueclinical"}]

    Find Clinical Drug Pipeline Developments & Deals by Vensica Therapeutics

    Menu

    Vensica Therapeutics

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Vensica Therapeutics

                            Israel arrow
                            Vitafoods
                            Not Confirmed

                            Vensica Therapeutics

                            Israel arrow
                            Vitafoods
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Xeomin

                            Therapeutic Area : Urology

                            Study Phase : Undisclosed

                            Sponsor : Blueclinical

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Clinical Trial for the Assessment of Safety, Usability and Efficacy of the Vixe Combination for OAB in Female ...

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Protein

                            Upfront Cash : Inapplicable

                            April 03, 2024

                            Lead Product(s) : Xeomin

                            Therapeutic Area : Urology

                            Highest Development Status : Undisclosed

                            Sponsor : Blueclinical

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Vensica Therapeutics

                            Israel arrow
                            Vitafoods
                            Not Confirmed

                            Vensica Therapeutics

                            Israel arrow
                            Vitafoods
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Incobotulinumtoxin A

                            Therapeutic Area : Urology

                            Study Phase : Phase III

                            Sponsor : Merz Pharma

                            Deal Size : $19.0 million

                            Deal Type : Partnership

                            DEALS_DEV arrow-down

                            Merz Strengthens Partnership With Start-up Vensica and Invests up to $3 million

                            Details : This investment follows the strategic license and collaboration agreement signed in 2021 to utilize Merz’s botulinum neurotoxin A (XEOMIN®) for the innovative ultrasound-assisted delivery catheter of Vensica.

                            Product Name : Xeomin

                            Product Type : Protein

                            Upfront Cash : Undisclosed

                            July 02, 2022

                            Lead Product(s) : Incobotulinumtoxin A

                            Therapeutic Area : Urology

                            Highest Development Status : Phase III

                            Sponsor : Merz Pharma

                            Deal Size : $19.0 million

                            Deal Type : Partnership

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth